ALOX15 and prostate carcinoma: As elevation in ALOX15 or its metabolites has been associated with increased risk of atherogenesis, metabolic dysfunction–associated steatotic liver disease, diabetes, stroke, Alzheimer’s disease, and breast and prostate cancer, detailed rephenotyping was performed (10, 24–30).